Media

Media

Zuvius Launches Cytraz in 100mg, 500mg and 1gm

Admin / May 16, 2015 / Graphic, Illustration, Logo

Zuvius Launches Cytraz in 100mg, 500mg and 1gm, used in the treatment of Cancers of white blood cells such as acute myeloied leukemia (AML) and non-Hodgkin Lymphoma.

CYTRAZ (CYTARABINE INJECTION BP)

COMPOISTION

Each ml contains:

Cytarabine BP……………………….100mg

Water for injection BP ……………....q.s.

Indications :

Cytarabine is useful in various neoplastic disorders including acute lymphocytic leukemia (ALL), acute myelogenous leukemia (AML), acute nonlymphocytic leukemia (ANILL), chronic myeloid leukemia, acute promyelocytic leukemia, meningeal neoplasms, and carcinomatous meningitis. Cytarabine may be effective in the treatment of Non-Hodgkin’s Lymphoma, malignant pleural effusions, multiple myeloma, myelodysplastic syndrome and Leukoencephalopathy. Other disease state in which cytarabine has been used include herpes virus infections and psorials.

Packing :

100 mg/1mL Single-Use Vial

500 mg/5mL Single-Use Vial

1000 mg/10mL Single-Use Vial

TOP
Login
Forgot Password ?

Not a member as yet? Register Now

In case you are using a public/shared computer we recommend that
you logout to prevent any un-authorized access to your account

forgot password

Reset Your Password

Enter email address to receive an email with the link to reset your password.

New User

hello , who are you?

I am a? *

Create Login Details

your contact details

I have read and understood and agree to Terms and Conditions the governing the use of zuviuslifescience.in.